The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis

Cladribine Tablets (MAVENCLAD(®)) are used to treat relapsing multiple sclerosis (MS). The recommended dose is 3.5 mg/kg, consisting of 2 annual courses, each comprising 2 treatment weeks 1 month apart. We reviewed the clinical pharmacology of Cladribine Tablets in patients with MS, including pharma...

Descripción completa

Detalles Bibliográficos
Autores principales: Hermann, Robert, Karlsson, Mats O., Novakovic, Ana M., Terranova, Nadia, Fluck, Markus, Munafo, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373393/
https://www.ncbi.nlm.nih.gov/pubmed/29987837
http://dx.doi.org/10.1007/s40262-018-0695-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373393/
https://www.ncbi.nlm.nih.gov/pubmed/29987837
http://dx.doi.org/10.1007/s40262-018-0695-9

Ejemplares similares